Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PAIYY
Upturn stock ratingUpturn stock rating

Aesthetic Medical International Holdings Group Limited (PAIYY)

Upturn stock ratingUpturn stock rating
$0.28
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

03/26/2025: PAIYY (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -93.41%
Avg. Invested days 14
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 03/26/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 9.61M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 4024
Beta -0.18
52 Weeks Range 0.12 - 0.90
Updated Date 02/26/2025
52 Weeks Range 0.12 - 0.90
Updated Date 02/26/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.15

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -6.66%
Operating Margin (TTM) -4.86%

Management Effectiveness

Return on Assets (TTM) -6.49%
Return on Equity (TTM) -242.08%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 36372627
Price to Sales(TTM) 0.01
Enterprise Value 36372627
Price to Sales(TTM) 0.01
Enterprise Value to Revenue 0.36
Enterprise Value to EBITDA 14.11
Shares Outstanding 47788000
Shares Floating 16414002
Shares Outstanding 47788000
Shares Floating 16414002
Percent Insiders -
Percent Institutions 0.04

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Aesthetic Medical International Holdings Group Limited

stock logo

Company Overview

overview logo History and Background

Aesthetic Medical International Holdings Group Limited (AIH) was founded in China and is a provider of aesthetic medical services. It went public through a reverse merger; its historical evolution involves strategic expansions within the Chinese market.

business area logo Core Business Areas

  • Surgical Aesthetic Treatments: Offers a range of surgical procedures, including facial plastic surgery, breast augmentation, and liposuction.
  • Non-Surgical Aesthetic Treatments: Provides non-invasive treatments such as laser skin resurfacing, botulinum toxin injections, and dermal fillers.

leadership logo Leadership and Structure

Information on AIH leadership is limited and is based around the current board of directors. The organizational structure is based around treatment services for Aesthetic Medical treatments.

Top Products and Market Share

overview logo Key Offerings

  • Facial Plastic Surgery: Includes procedures such as rhinoplasty, blepharoplasty, and facelifts. Competitors in this area include other clinics offering similar surgical procedures.
  • Dermal Fillers and Botulinum Toxin Injections: Provides wrinkle reduction and facial contouring services. Competitors include Allergan (ABBV) and Galderma.

Market Dynamics

industry overview logo Industry Overview

The aesthetic medical industry is driven by increasing demand for appearance-enhancing procedures. Growth is fueled by disposable income and societal beauty standards.

Positioning

AIH is a prominent player in the Chinese aesthetic medical market; however, its US presence and influence is limited. Competitively, it relies on its local market expertise.

Total Addressable Market (TAM)

The global aesthetic medicine market is projected to reach several billion USD. AIH's position primarily focuses on the Chinese portion of this TAM.

Upturn SWOT Analysis

Strengths

  • Established presence in China
  • Wide range of aesthetic medical services
  • Brand recognition in its local market

Weaknesses

  • Limited international presence, US Market Exposure
  • Dependence on the Chinese economy
  • Regulatory risks in the aesthetic medical industry

Opportunities

  • Expanding service offerings
  • Acquiring smaller clinics
  • Leveraging digital marketing

Threats

  • Increased competition
  • Changing consumer preferences
  • Economic downturns

Competitors and Market Share

competitor logo Key Competitors

  • ABBV
  • SNY
  • ZTS

Competitive Landscape

AIH faces competition from larger international players and local Chinese clinics. Its success hinges on local market knowledge.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Historical growth is based on expansion in China.

Future Projections: Future growth relies on capturing more market share in China, with uncertain prospects in the US.

Recent Initiatives: Recent initiatives focus on attracting younger patients.

Summary

Aesthetic Medical International Holdings Group Limited has a strong presence in China but limited exposure to the US market. Expansion and competition remain significant challenges. Success is tied to its ability to navigate the Chinese market effectively and remain competitive. A lack of public financial data hinders comprehensive analysis.

Similar Companies

  • ABBV
  • SNY
  • ZTS

Sources and Disclaimers

Data Sources:

  • Company press releases
  • Industry reports
  • Analyst estimates

Disclaimers:

Data provided is for informational purposes only and should not be considered financial advice. Market share figures are estimates and may not be precise.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Aesthetic Medical International Holdings Group Limited

Exchange NASDAQ
Headquaters -
IPO Launch date 2019-10-25
CEO -
Sector Healthcare
Industry Medical Care Facilities
Full time employees 1286
Full time employees 1286

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China and Singapore. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​